OMNIDEL
Live / Applied — Third extension granted (statement of use) (as of 21 Jul 2025)
What this means for you
Not registered yet, but its 09 Feb 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97788090
- Mark type
- Stylized text
- Filed
- 09 Feb 2023
- Published for opposition
- 12 Dec 2023
- Attorney of record
- Brendan J. Hughes
Goods and services
- Class 042 — Scientific and technological services: Drug discovery services; pharmaceutical research and development services
Owner
- Totus Medicines Inc., Emeryville, CA, US
- Totus Medicines Inc., Emeryville, CA, US
Prosecution history
- 03 Feb 2026 — TEAS STATEMENT OF USE RECEIVED
- 03 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 22 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Jul 2025 — SOU EXTENSION 3 GRANTED
- 21 Jul 2025 — SOU EXTENSION 3 FILED
- 21 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 07 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Feb 2025 — SOU EXTENSION 2 GRANTED
- 06 Feb 2025 — SOU EXTENSION 2 FILED
- 06 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jul 2024 — SOU EXTENSION 1 GRANTED
- 15 Jul 2024 — SOU EXTENSION 1 FILED
- 15 Jul 2024 — SOU TEAS EXTENSION RECEIVED
- 06 Feb 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT